The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies
Open accessAbstract
BACKGROUND: Endometriosis is a risk factor for epithelial ovarian cancer; however, whether this risk extends to all invasive histological subtypes or borderline tumours is not clear. We undertook an international collaborative study to assess the association between endometriosis and histological subtypes of ovarian cancer. METHODS: Data from 13 ovarian cancer case-control studies, which were part of the Ovarian Cancer Association Consortium, were pooled and logistic regression analyses were undertaken to assess the association between self-reported endometriosis and risk of ovarian cancer. Analyses of invasive cases were done with respect to histological subtypes, grade, and stage, and analyses of borderline tumours by histological subtype. Age, ethnic origin, study site, parity, and duration of oral contraceptive use were included in all analytical models. FINDINGS: 13 226 controls and 7911 women with invasive ovarian cancer were included in this analysis. 818 and 738, respectively, reported a history of endometriosis. 1907 women with borderline ovarian cancer were also included in the analysis, and 168 of these reported a history of endometriosis. Self-reported endometriosis was associated with a significantly increased risk of clear-cell (136 [20·2%] of 674 cases vs 818 [6·2%] of 13 226 controls, odds ratio 3·05, 95% CI 2·43-3·84, p<0·0001), low-grade serous (31 [9·2%] of 336 cases, 2·11, 1·39-3·20, p<0·0001), and endometrioid invasive ovarian cancers (169 [13·9%] of 1220 cases, 2·04, 1·67-2·48, p<0·0001). No association was noted between endometriosis and risk of mucinous (31 [6·0%] of 516 cases, 1·02, 0·69-1·50, p=0·93) or high-grade serous invasive ovarian cancer (261 [7·1%] of 3659 cases, 1·13, 0·97-1·32, p=0·13), or borderline tumours of either subtype (serous 103 [9·0%] of 1140 cases, 1·20, 0·95-1·52, p=0·12, and mucinous 65 [8·5%] of 767 cases, 1·12, 0·84-1·48, p=0·45). INTERPRETATION: Clinicians should be aware of the increased risk of specific subtypes of ovarian cancer in women with endometriosis. Future efforts should focus on understanding the mechanisms that might lead to malignant transformation of endometriosis so as to help identify subsets of women at increased risk of ovarian cancer. FUNDING: Ovarian Cancer Research Fund, National Institutes of Health, California Cancer Research Program, California Department of Health Services, Lon V Smith Foundation, European Community's Seventh Framework Programme, German Federal Ministry of Education and Research of Germany, Programme of Clinical Biomedical Research, German Cancer Research Centre, Eve Appeal, Oak Foundation, UK National Institute of Health Research, National Health and Medical Research Council of Australia, US Army Medical Research and Materiel Command, Cancer Council Tasmania, Cancer Foundation of Western Australia, Mermaid 1, Danish Cancer Society, and Roswell Park Alliance Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“endometrioid cancer (OR 2.21)”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“It is becoming clear that epigenetics and genomic instability associated with the particular microenvironment of endometriosis characterized by oxidative stress, inflammatory process and high estrogen levels contribute to the process of malignant transformation of endometriosis (Pearce et al., 2012, Nezhat et al., 2014).”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al., 2012
In the citing paper
“and low-grade serous invasive ovarian cancers (OR 2.21).”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“Pearce et al. (2012), concluded that self-reported endometriosis was associated with significantly increased risk for CCC [odds ratio (OR) 3.05]”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“Pearce et al. summarized 13 case-control studies and reported the highest odds ratio of 3.05 for clear cell carcinoma, followed by LG-serous (2.11) and endometrioid carcinoma (2.04) in patients with endometriosis [9].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“Malignant transformation of ovarian endometriosis has been well documented.”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“In population-based studies, the incidence of ovarian cancer in patients with a history of ovarian endometriosis is 1.35-1.49times greater compared with those without this history [9,10].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“Of these, we observed associations with multiple diseases or traits, including epithelial ovarian cancer21, low-density lipoprotein cholesterol22, coronary heart disease23, luteinizing hormone and follicle-stimulating hormone levels, and age at onset for menopause24.”
From Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism (2017) · cites this paper as [21]
In the citing paper
“Most recently, in a study of 13 226 controls and 7911 women with invasive ovarian cancer, self-reported endometriosis was associated with a significantly increased risk of clear-cell, low-grade serous, and endometrioid invasive ovarian cancers.”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“No association was noted between endometriosis and risk of mucinous or high-grade serous invasive ovarian cancer or borderline tumors of either subtype.118”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“Endometriosis and ovarian cancer have been linked by a number of studies.”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“which have been (suggested to be) associated with endometriosis or its constituting symptoms in epidemiologic studies (51–54).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Kurman, R. J., & Shih, I. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf3d79 · Cited by 1,890
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Self-citationEskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
Kurman, R. J., & Shih, I. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.03.003 · Cited by 1,099
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events
Bradburn, M. J., Deeks, J. J., Berlin, J. A., & Russell Localio, A. (2007) · Statistics in Medicine · doi:10.1002/sim.2528 · Cited by 938
Ovarian Tumors in a Cohort of Infertile Women
Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E., & Self, S. G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311204 · Cited by 721
Self-citationCancer risk after a hospital discharge diagnosis of endometriosis
Brinton, L. A., Gridley, G., Persson, I. R., Baron, J. A., & Bergqvist, A. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70550-7 · Cited by 549
Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies
Ness, R. B. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.3.217 · Cited by 425
Self-citationRisk of cancer after use of fertility drugs with in-vitro fertilisation
Venn, A., Watson, L., Bruinsma, F., Giles, G. G., & Healy, D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05203-4 · Cited by 368
Endometriosis and the risk of cancer with special emphasis on ovarian cancer
Melin, A., Sparén, P., Persson, I., & Bergqvist, A. (2006) · Human Reproduction · doi:10.1093/humrep/dei462 · Cited by 306
Cited by
Sorted by citations
Items 901–946 of 946
Batista, M. D. P., Roffé, M., Romero, I., López-Guerrero, J. A., Illueca, C., Lopez, R., Balieiro Anastácio da Costa, A. A., De Brot, L., Molina, J. P., Barboza, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26601508
Batista, M. D. P., Roffé, M., Romero, I., López-Guerrero, J. A., Illueca, C., Lopez, R., Balieiro Anastácio da Costa, A. A., De Brot, L., Molina, J. P., Barboza, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26601502
Batista, M. D. P., Roffé, M., Romero, I., López-Guerrero, J. A., Illueca, C., Lopez, R., Balieiro Anastácio da Costa, A. A., De Brot, L., Molina, J. P., Barboza, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26601514
Batista, M. D. P., Roffé, M., Romero, I., López-Guerrero, J. A., Illueca, C., Lopez, R., Balieiro Anastácio da Costa, A. A., De Brot, L., Molina, J. P., Barboza, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26601505
Batista, M. D. P., Roffé, M., Romero, I., López-Guerrero, J. A., Illueca, C., Lopez, R., Balieiro Anastácio da Costa, A. A., De Brot, L., Molina, J. P., Barboza, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26601520
Zhu, C., Zhu, J., Qian, L., Liu, H., Shen, Z., Wu, D., Zhao, W., Xiao, W., & Zhou, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14314567
Batista, M. D. P., Roffé, M., Romero, I., López-Guerrero, J. A., Illueca, C., Lopez, R., Balieiro Anastácio da Costa, A. A., De Brot, L., Molina, J. P., Barboza, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26601499
Yin, M., Lu, C., Zhou, H., Liu, Q., & Yang, J. (2023) · Figshare · doi:10.6084/m9.figshare.23292039
Nanotechnology for combating chemoresistance in ovarian cancer
Mishra, N., Yadav, M., Saddick, S., Berneau, S., Sharma, J. G., Chandra, R., & Singh, K. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33343-9.00009-0
Lu, M., Chu, Y., Zhu, Z., Zhou, H., Zhu, D., Chen, S., Bu, C., Qian, Q., Gao, C., Jiang, M., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.01.014
Marcellin, L., Maignien, C., Bourdon, M., Chapron, C., & Santulli, P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00298-3
Brenner tumor associated with mucinous cyst and endometriosis: a case report
Ramezani, F., Mashoufi, R., Mashoufi, R., & Karimi, M. (2026) · International Journal of Surgery Case Reports · doi:10.1097/rc9.0000000000000180
Epithelial Tumors of the Ovary
Lee, E. J., Park, S. B., & Moon, M. H. (2026) · Springer eBooks · doi:10.1007/978-981-95-2427-3_20
Bartiromo, L., Ferrari, S. M., Schimberni, M., Delfanti, E., Sangiorgi, V., Tandoi, I., Ottolina, J., & CANDIANI, M. (2026) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2026.115074
Génétique et épigénétique de l'endométriose : analyse des micro-ARNs et séquençage de familles
Abo, C. (2020) · theses.fr (ABES) · doi:10.70675/1f196b86zdff4z4171zaff3zba99042c1a5d
Exploitation du défaut de réparation de l'ADN à l'aide de la stratégie d'inhibition de CDK
Orhan, E. (2022) · theses.fr (ABES) · doi:10.70675/40065dd4z1f5bz4361zaa67z59acc4e5d6c2
Endometriose und Karzinogenese
Küpker, W., Felberbaum, R. E., Bullerdiek, J., Aizpurúa, J., Mechsner, S., Ulrich, U. A., & Diedrich, K. (2026) · Gynäkologische Endokrinologie · doi:10.1007/s10304-026-00685-x
Dedifferentiated Carcinoma of the Ovary: A Rare Aggressive Subtype
Bansal, D., Kamboj, M., Sharma, A., & Mehta, A. (2026) · Cureus · doi:10.7759/cureus.107153
Lignes directrices de pratique clinique n° 468 : Prise en charge clinique de l'endométriose
Yong, P. J., Allaire, C., Bedaiwy, M. A., Bougie, O., Kives, S. L., Maheux‐Lacroix, S., Murji, A., Singh, S. S., Amoako, E., Bajzak, D. K., et al. (2026) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2026.103383
Liu, Y., Yin, D., Wu, L., Wang, H., Song, Y., Huang, J., Zhou, J., Li, H., Liang, P., & He, H. M. (2026) · Scientific Reports · doi:10.1038/s41598-026-51155-0
Research Progress on Endometriosis-Associated Ovarian Cancer
余, 平. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1651847
Green, J. A. (2026) · Springer eBooks · doi:10.1007/978-3-032-14420-1_7
Matheu, G., Bermejo-Pérez, M. J., Escudero-García, N., García-Durán, C., Calderó, S. G., Guerra-Alía, E. M., López-Agulló, S., Romero, I., Zambrano, G. G. Y., & Barretina-Ginesta, M. P. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04335-3
Kuroda, T., Giannone, G., Ennis, D. P., Mirza, H., Marks, D., Flood, L., Sisley, M., Griffin, R., Desai, S., McDermott, J. R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.29.728698
Shibata, T., Takata, E., Shioya, A., Yamada, S., Ura, H., Niida, Y., Yasumoto, K., & Takakura, M. (2026) · JCO Precision Oncology · doi:10.1200/po-26-00056
Sánchez-Gómez, R., Soler-Gabaldon, S., Gomez-Meseguer, C., Lorente-Gea, L., Torroba, A., Marín‐Sánchez, P., & Machado‐Linde, F. (2026) · Research Square · doi:10.21203/rs.3.rs-9723381/v1
Epidemiology of endometriosis and adenomyosis
Upson, K., Missmer, S. A., Tellum, T., Harris, H. R., & As‐Sanie, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00031-7
Wentzensen, N., Trabert, B., & Schildkraut, J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00070-6
Self-citationHuang, X., Liu, X., Dai, H., & Xu, M. (2026) · BMC Women s Health · doi:10.1186/s12905-026-04621-w
From cytoreduction to precision oncology: evolution of ovarian cancer therapy
Saed, G. M., Detti, L., Massad, D., Basha, A., & Morris, R. T. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02165-z
Molecular Pathology of Epithelial Ovarian Cancer
Porcayo, M. A. T. (2026) · Springer eBooks · doi:10.1007/978-3-032-13454-7_37
Porcayo, M. A. T., del Castillo, V. T. G., & del Castillo, A. C. T. G. (2026) · Springer eBooks · doi:10.1007/978-3-032-13454-7_36
Oo, M. H., Kyaw, E. M. M., & Alhindawi, B. (2026) · Cureus · doi:10.7759/cureus.114062
Iacobelli, V., Mastrantoni, L., Alivernini, S., Scaglione, G., Agostini, A., Mantini, G., Piermattei, A., Persiani, F., Camarda, F., Trozzi, R., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10497180/v1
Biosimilars and biologics in ovarian cancer
Chaudhari, D., Ghode, P., & Anitha, K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-43824-0.00011-0
Elkeeb, A. (2026) · AlQalam Journal of Medical and Applied Sciences · doi:10.54361/ajmas.269942
Kwas, K., Lisińska, W., Koziróg, E., Stanek, K., Wolder, D. P., Szubert, M., & Wilczyński, J. R. (2026) · Cancers · doi:10.3390/cancers18183036
Spatial heterogeneity of hotspot mutations and clonal relatedness in ovarian endometrioid carcinoma
Ashihara, T., Murakami, K., Takamatsu, S., Kanto, A., Mori, S., Otani, T., Sakai, K., Kotani, Y., Nishio, K., Abiko, K., et al. (2026) · Molecular Oncology · doi:10.1002/1878-0261.70347
Meyer, R., Sun, J., Lombardi, C. A., Shats, M., Yu, P. H., Abbasi, F., Berberian, A., Manlinguez, A., Kulkarni, S., Pisarska, M., et al. (2026) · European Journal of Obstetrics & Gynecology and Reproductive Biology X · doi:10.1016/j.eurox.2026.100500
Self-citationMasha, F. L., Thobakgale, N. M., & Khaba, M. C. (2026) · Journal of the Colleges of Medicine of South Africa · doi:10.4102/jcmsa.v4i1.421
Liu, S., & Sun, C. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-026-10385-4
To, G., Shinto, A., Fukuda, A., 橋口, 真., Kato, S., Umezaki, Y., & Okugawa, K. (2026) · Case Reports in Women s Health · doi:10.1016/j.crwh.2026.e00866
Matias, M. R. D. S. S., de Araújo, L. M., Cruzio, A. S., Azevedo, F. H. C., Pinheiro, A. M. P. A. L., & dos Santos, A. R. (2026) · Revista Arte Ciência e Tecnologia · doi:10.29327/2405020.34.1-7
Liu, Z., Liu, Y., Qiang, R., Zhu, Y., Chen, Y., He, Q., Fang, J., Zhou, X., & Wang, Y. (2026) · Biomedicines · doi:10.3390/biomedicines14112436
Chatterjee, K., Jana, S., DasMahapatra, P., & Swarnakar, S. (2026) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/22840265261497322
Ovarian Cancer Therapy Today and Tomorrow: Unmet Needs, Innovations, and Clinical Pathways
Tannous, J. C., Maimaitiming, D., Yeku, O., Xu, L., & Amoozgar, Z. (2026) · Gynecologic Cancer · doi:10.3390/gynecolcancer1010002
Metadata
- Authors
- Pearce, C. L., Templeman, C., Rossing, M. A., Lee, A., Near, A. M., Webb, P. M., Nagle, C. M., Doherty, J. A., Cushing-Haugen, K. L., Wicklund, K. G., Chang-Claude, J., Hein, R., Lurie, G., Wilkens, L. R., Carney, M. E., Goodman, M. T., Moysich, K., Kjaer, S. K., Hogdall, E., Jensen, A., Goode, E. L., Fridley, B. L., Larson, M. C., Schildkraut, J. M., Palmieri, R. T., Cramer, D. W., Terry, K. L., Vitonis, A. F., Titus, L. J., Ziogas, A., Brewster, W., Anton-Culver, H., Gentry-Maharaj, A., Ramus, S. J., Anderson, A. R., Brueggmann, D., Fasching, P. A., Gayther, S. A., Huntsman, D. G., Menon, U., Ness, R. B., Pike, M. C., Risch, H., Wu, A. H., & Berchuck, A.
- Affiliations
- University of Southern California (US)
- Fred Hutch Cancer Center (US)
- Georgetown University Medical Center (US)
- QIMR Berghofer Medical Research Institute (AU)
- German Cancer Research Center (DE)
- University of Hawaiʻi at Mānoa (US)
- Roswell Park Comprehensive Cancer Center (US)
- Danish Cancer Society (DK)
- Mayo Clinic (US)
- Duke Medical Center (US)
- Brigham and Women's Hospital (US)
- Dartmouth College (US)
- University of California, Irvine (US)
- University of North Carolina at Chapel Hill (US)
- University College London (GB)
- University of California, Los Angeles (US)
- Yale University (US)
- Corresponding author
- Pearce, Celeste Leigh
- ORCID
- Pearce, Celeste Leigh
- Lee, Alice
- Near, Aimee M
- Webb, Penelope M
- Nagle, Christina M
- Doherty, Jennifer A
- Wicklund, Kristine G
- Wilkens, Lynne R
- Goodman, Marc T
- Moysich, Kirsten
- Jensen, Allan
- Goode, Ellen L
- Fridley, Brooke L
- Larson, Melissa C
- Schildkraut, Joellen M
- Cramer, Daniel W
- Terry, Kathryn L
- Titus, Linda J
- Ziogas, Argyrios
- Brewster, Wendy
- Ramus, Susan J
- Fasching, Peter A
- Gayther, Simon A
- Menon, Usha
- Pike, Malcolm C
- Risch, Harvey
- Wu, Anna H
- Berchuck, Andrew
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 13
- Issue
- 4
- Pages
- 385-394
- ISSN
- 1470-2045 (ISSN-L)
- PMC
- PMC3664011
- OpenAlex
- W2125681453
- Cited by
- 939
- References
- 43
- Citations by year
- 2026: 47 · 2025: 53 · 2024: 46 · 2023: 64 · 2022: 44 · 2021: 84 · 2020: 88 · 2019: 77 · 2018: 71 · 2017: 83 · 2016: 68 · 2015: 65 · 2014: 55 · 2013: 68 · 2012: 26
- FWCI
- 79.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Lancet Oncology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- California Breast Cancer Research Program (0001389V20170, 2110200)
- Seventh Framework Programme (HEALTH-F2-2009-223175)
- University of South China
- National Institutes of Health (5R01 CA074850, CA14089, CA17054, CA58860, CA61132, CA92044, N01 CN67001, N01 PC35137, N01 PC67010, P50 CA105009, P50 CA136393, PSA 042205, R01 CA112523, R01 CA122443, R01 CA126841, R01 CA136891, R01 CA54419, R01 CA58598, R01 CA61107, R01 CA76016, R01 CA87538, R01 CA95023, R03 CA113148)
- Medical Research and Materiel Command (DAMD 170110729, DAMD17-02-1-0669, W81XWH0610220, W81XWH1010280)
- Oak Foundation
- Lon V. Smith Foundation (LVS 39420)
- California Department of Public Health (050E8709)
- Roswell Park Alliance Foundation, Roswell Park Cancer Institute
- Kræftens Bekæmpelse
- Deutsches Krebsforschungszentrum
- National Health and Medical Research Council (199600)
- Cancer Council Tasmania
- American University of Sharjah
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- endometriosis, ovarian cancer, histological subtypes, ovarian clear cell carcinoma, low-grade serous ovarian cancer, endometrioid ovarian cancer, mucinous ovarian carcinoma, high-grade serous ovarian cancer, borderline ovarian tumors, cancer risk factors, oral contraceptive use, parity, tumor stage and grade, Ovarian Cancer Association Consortium
- MeSH terms
- Aged, Aged, 80 and over, Endometriosis, Ethnicity, Female, Humans, Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, Ovarian Neoplasms, Risk Factors, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
